Here are relevant reports on : nephroprotective-drugs-market
-
Grignard Reagents Market by Product Type (Alkyl Grignard Reagents, Vinyl Grignard Reagents, Aryl Grignard Reagents), Application (APIs & Drugs, Agrochemicals, Polymer Synthesis & Functionalization), End-use Industry (Pharmaceutical & Biotechnology, Agriculture, Chemical, Flavors & Fragrances, Research), and Region - Global Forecast to 2030
The grignard reagents market is expected to grow from USD 5.07 billion in 2025 to USD 6.67 billion in 2030, at a CAGR of 5.6% during the forecast period. Prominent companies in this market include Merck KGaA (Germany), Albemarle Corporation (US), WeylChem International GmbH (Germany), HOKKO CHEMICAL INDUSTRY CO., LTD. (Japan), CHEMIUM srl (Belgium), FAR Chemical (US), PMC Group, Inc (US), Boulder Scientific Group (US), Neogen Chemicals Ltd (India), Tokyo Chemical Industry (India) Pvt. Ltd. (India), Optima Chem (US), Shaoxing Shangyu Hualun Chemical Co., Ltd. (China), Nanjing Freehoo Chemical Technology Co., Ltd (China), Chemische Fabrik Karl Bucher GmbH (Germany), and Jiangsu Changjili New Energy Technology Co., Ltd. (China).
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs by (CLL, ALL, CML, AML)), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024
The leukemia therapeutics market is projected to reach USD 17.1 billion by 2024, at a CAGR of 6.8%. Market growth is largely driven by the rising prevalence of acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML) and increasing approvals of novel & innovative drugs and immunotherapies. The major players in this market are AbbVie (US), Bristol-Myers Squibb (US), Novartis (Switzerland, F. Hoffmann-La Roche (Switzerland), Pfizer (US), Sanofi (France), Amgen (US), Gilead Sciences (US), Takeda Pharmaceutical (Japan), and Celgene (US). Product approvals are a key strategy adopted by key players in order to enhance their dominance in this market.
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Renal Cancer Drugs Market by therapy (targeted therapy, chemotherapy, and immunotherapy), drug class (anti-angiogenesis, mTOR inhibitors, interleukin, and immune checkpoint inhibitors), indication (renal cell carcinoma, urothelial carcinoma, and others), distribution channel (hospitals, specialty & retail pharmacies and others), and region (North America, Europe, Asia Pacific and Rest of the World (RoW) which includes Latin America and Middle East & Africa) – global forecasts to 2027
The renal cancer drugs market is projected to reach USD 8 billion by 2027 from USD 6 billion in 2022, at a CAGR of 6% during the forecast period.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Peptide and Anticoagulant Drugs Market by Type (Hormonal (Insulin, Teriparatide, Calcitonin), Antibiotic (Colistin, Cycloserine), Low molecular weight heparin (Enoxaparin Sodium, Heparin Sodium), Application (Diabetes, Cancer) - Global Forecast to 2022
The Indian peptide drugs market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%. Factors such as increasing prevalence of chronic diseases, rising aging population, and increasing healthcare expenditure are contributing to the growth of this market. The Indian anticoagulant drugs market is expected to reach USD 170.2 Million in 2022 from USD 127.8 Million in 2016 and is expected to register a CAGR of 4.9%. Factors such as incidence of coagulation disorders and government support for pharmaceutical companies are contributing to the growth of this market. Some of the major players operating in the Indian anticoagulant drugs market are Sanofi (France), Emcure Pharmaceutical Pvt. Ltd. (India), Cipla Ltd. (India), Bharat Serum (India), Pfizer Inc. (US), Abbott Laboratories (U.S.), Lupin Ltd. (India), Dr. Reddy’s Laboratories (India), Intas Pharmaceuticals Ltd. (India), Samarth Life Sciences (India), Claris Lifesciences Limited (India), Gland Pharma Limited (India), Mylan Pharmaceutical (India), Torrent Pharmaceuticals (India), Micro Labs Ltd. (India), and VHB Lifesciences (India).
- Published: August 2017
- Price: $ 7150
- TOC Available:
-
US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Global Forecast to 2022
The US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%. The US anticoagulation therapy market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US anticoagulation therapy market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices.
- Published: November 2017
- Price: $ 4950
- TOC Available:
-
Beverage Dispenser Market by Type, Component, End-Use, Industry, Application and Region - Global Forecast from 2028 to 2030
The beverage dispenser market is the industry that manufactures, distributes, and sells devices or equipment that dispense various types of beverages. Beverage dispensers are utilized in both commercial and residential contexts, such as restaurants, hotels, cafes, convenience stores, and other foodservice establishments.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Clinical Trial Packaging Market - Global Forecast to 2024
This study will involve the extensive use of both primary and secondary sources. The research process will involve the study of various factors affecting the industry, to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Healthcare Contract Management Software Market by Product & Service (Contract Lifecycle Management, Document Management), End User (Healthcare Providers, Hospitals, Physicians, Payers, Medical Device Manufacturers, Pharma) & Region - Global Forecasts to 2024
The healthcare contract management software market is projected to reach USD 1,763 million by 2024, growing at a CAGR of 18.5%. The prominent players in this market are Determine Inc. (US), CobbleStone Software (US), Concord (US), Contract Logix LLC (US), Icertis (US), Apttus Corporation (US), Coupa Software Inc. (US), Optum Inc. (US), nThrive Inc. (US), Experian Plc. (Ireland), and ScienceSoft (US).
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Retort Packaging Market by Type (Pouches, Trays, and Cartons), Material (PET, Polypropylene, Aluminum foil, PA, PE, and Paperboard), End-use (Food and Beverages), and Region - Global Forecast to 2025
The Retort Packaging Market is expected to grow from USD 3.5 billion in 2020 to USD 4.5 billion by 2025, at a CAGR of 5.1% during the forecast period. Amcor PLC (Australia), Berry Global Inc. (US), Sonoco (US), Huhtamaki Oyj (Finland), Mondi Group (South Africa), and Coveris (Us) are the key players operating in the retort packaging market. Expansions, acquisitions, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the cosmetic packaging market.
- Published: March 2020
- Price: $ 4950
- TOC Available:
-
Enterprise Performance Management Market by Component, Application (Enterprise Planning & Budgeting, Reporting & Compliance), Business Function, Deployment Type, Organization Size, Vertical and Region - Global Forecast to 2027
The global Enterprise Performance Management (EPM) Market size is projected to reach to reach USD 8.3 billion by 2027, at a Compound Annual Growth Rate (Compounded Annual Growth Rate) of 7.0% during the forecast period. The enterprise performance management market is dominated by companies such as Unicom Systems (US), Planful (US), Unit4 (Netherlands), OneStream (US), SAP (Germany), Oracle (US), IBM (US), Infor (US), Anaplan (US),Workday (US), Epicor Software (US), BearingPoint (Netherlands), Broadcom (US), Board International (Switzerland), LucaNet (Germany), Prophix (Canada), Vena Solutions (Canada), Solver (US), Kepion (US), Jedox (Germany), Wolters Kluwer (Netherlands), Corporater (Norway), insight software (US), and others. These vendors have a large customer base and strong geographic footprint along with organized distribution channels, which assists them to increase revenue generation.
- Published: June 2022
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
